National strategy for the prevention and management of transfusion-associated hepatitis

The screening of potential blood donors for the hepatitis B (HBV) and C (HCV) viruses has decreased the risk of transfusion-associated hepatitis. There remains, however, a lack of consensus on a number of issues including methods for screening of blood donors and the management of donors found to have markers of hepatitis virus infection. This document outlines the recommendations of a large group of interested individuals including blood transfusion service managers, primary care health authorities, epidemiologists, virologists, pathologists, gastroenterologists and hepatologists drawn from both the public and the private sector.